Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $40.1 million.

  • Cumberland Pharmaceuticals' Total Liabilities fell 2329.9% to $40.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.1 million, marking a year-over-year decrease of 2329.9%. This contributed to the annual value of $53.0 million for FY2024, which is 99.25% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Total Liabilities stood at $40.1 million for Q3 2025, which was down 2329.9% from $40.2 million recorded in Q2 2025.
  • Cumberland Pharmaceuticals' Total Liabilities' 5-year high stood at $57.0 million during Q4 2022, with a 5-year trough of $40.1 million in Q3 2025.
  • For the 5-year period, Cumberland Pharmaceuticals' Total Liabilities averaged around $49.1 million, with its median value being $52.3 million (2022).
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 3605.86% in 2022, then crashed by 2342.55% in 2025.
  • Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Total Liabilities stood at $41.9 million in 2021, then soared by 36.06% to $57.0 million in 2022, then fell by 7.79% to $52.5 million in 2023, then grew by 0.99% to $53.0 million in 2024, then fell by 24.4% to $40.1 million in 2025.
  • Its Total Liabilities stands at $40.1 million for Q3 2025, versus $40.2 million for Q2 2025 and $41.6 million for Q1 2025.